Outlook Therapeutics Inc.
(OTLK)
undefined
undefined%
At close: undefined
2.38
-0.21%
After-hours Jan 06, 2025, 07:50 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Net Income | -75,366.70B | -58.98M | -66.05M | -53.16M | -35.24M | -34.52M | -46.11M | -38.85M | -53.33M | -48.67M | -13.73M |
| Depreciation & Amortization | 113.86B | 44.19K | 204.69K | 262.14K | 554.07K | 3.36M | -3.05M | 2.69M | 2.39M | 1.82M | 878.48K |
| Stock-Based Compensation | 5,385.10B | 5.55M | 7.71M | 4.89M | 2.81M | 1.31M | 1.99M | 8.57M | 12.45M | 11.18M | 3.96M |
| Other Working Capital | -4.41M | 1.67M | -2.98M | -6.88M | 220.04K | -11.86M | -6.97M | 5.44M | -1.50M | 531.77K | 1.96M |
| Other Non-Cash Items | 1,073.90B | 5.66M | 3.15M | 341.55K | -881.33K | 1.31M | 7.68M | 4.01M | 13.46K | 12.26K | 12.26K |
| Deferred Income Tax | n/a | n/a | n/a | 498.49K | 2.24M | 9.44M | 20.15M | -3.10M | 13.65K | n/a | n/a |
| Change in Working Capital | -3.02M | 4.75M | -1.68M | -7.08M | -1.27M | -13.19M | -13.68M | 11.16M | -7.02M | 8.18M | 1.86M |
| Operating Cash Flow | -68,793.90B | -42.97M | -56.67M | -54.25M | -31.79M | -32.29M | -33.04M | -15.51M | -45.48M | -27.48M | -7.02M |
| Capital Expenditures | n/a | -2 | n/a | n/a | n/a | -437.31K | -2.78M | -292.09K | -1.10M | -8.80M | -2.37M |
| Acquisitions | n/a | n/a | n/a | n/a | -900.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | -900.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | 900.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | -900.00K | -437.31K | -2.78M | -292.09K | -1.10M | -8.80M | -2.37M |
| Debt Repayment | -4.27K | 19.77M | -2.32M | 6.31M | 640.92K | -6.94M | -990.64K | 11.33M | -13.34M | 1.58M | 4.39M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -226.00K | -4.13M |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | -1,886.90B | -16.98B | n/a | n/a | n/a |
| Other Financial Acitivies | 60,329.40B | -823.89K | -394.15K | 3.59M | 1.14M | 4.35K | 20.65M | 16.99B | -6.21K | 172.79K | 7.11M |
| Financial Cash Flow | 60,329.40B | 48.97M | 59.59M | 56.19M | 37.21M | 39.03M | 34.35M | 16.63M | 39.86M | 43.00M | 11.47M |
| Net Cash Flow | -8,464.40B | 6.00M | 2.92M | 1.94M | 4.52M | 6.30M | -1.47M | 833.63K | -6.72M | 6.72M | 2.09M |
| Free Cash Flow | -68,793.90B | -42.97M | -56.67M | -54.25M | -31.79M | -32.73M | -35.82M | -15.80M | -46.58M | -36.28M | -9.39M |